ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy
Clinical trial NCT05392699 · RECRUITING
Trial details
- NCT number
- NCT05392699
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2025-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.